Press | May 7, 2015
Following RxData’s expansion into Switzerland, Lawrence Monoson was nominated as one of Switzerland’s top innovators by l’Hebdo, a Swiss magazine with more than 166,000 readers. The article refers to RxData as the “Bloomberg for Pharma”, nickname that has been getting increasing traction across Europe and the U.S. Once again, RxData is portrayed as an entity solving an unmet need, making market access information more accessible. HEBDO (link to article)
